This job has expired

You will need to login before you can apply for a job.

Director, Head of RNA Vaccine Process and Chemistry

CSL Behring
Start date
May 8, 2023

View more

Job Details

Job Description

The Opportunity

Do you want to find solutions to public health challenges in a Biotech Research environment? CSL Vaccine Research has an exciting opportunity to join the growing team at our Vaccine Research and Development center in the Waltham MA. With expertise in influenza science, our team improve and extend our vaccine portfolio with disruptive technologies like next-generation mRNA. We operate as one integrated global research and development organization, drawing together expert staff from different countries to collaborate with us. Together, we're working to protect communities from seasonal influenza and global pandemic threats.

In this exciting and evolving business, the Head of RNA Vaccine Process and Chemistry will take the leading role of sa-mRNA vaccine research. You will lead the RNA Vaccine Process and Chemistry team and guide the innovation on RNA vaccine process and LNP chemistry. You will report to Head of Discovery Research and Research Strategy and serve in the Research Leadership Team and teams to provide scientific input on company projects and collaborate with external collaborators. 

The Role

Manage and grow the RNA Vaccine Process and Chemistry Function

  • Provide the team with scientific guidance on sa-mRNA and LNP production and process improvement
  • Provide the team with scientific guidance on innovation of LNP chemistry and alternative mRNA encapsulation
  • Oversee function daily activities and assure operation efficient within a timeline and budget and compliant with policies
  • Coordinate the collaboration within Research and with other departments beyond Research
  • Support career development and manage goals and performance reviews of team members

Develop scientific strategy for RNA Vaccine Process and Chemistry

  • Develop and present scientific strategy for RNA Vaccine Process and Chemistry to upper management forums for approval
  • Contribute to the progress of Research projects through RNA vaccine production
  • Contribute to Research mRNA platform improvement through innovation of RNA process and lipid chemistry
  • Create and support generation of IP

Evaluate external opportunities and design experimental plan to demonstrate value

  • Identify opportunities by being an active member of the external scientific community
  • Review opportunities as provided to Research by other functions or external groups
  • Develop external partnerships through academic and industrial networks

Your skills and experience
  • PhD in Chemistry, Chemistry Engineering or related fields is required. Postdoc training in lipid chemistry is advantageous
  • 10+ years of in-depth knowledge, experience and a track record in lipid nanoparticle for mRNA delivery is required
  • Experience to support cohesive short- and long-term R&D strategies to support the future growth of the company.
  • Leadership experience to develop talent and achieve results through teamwork with streamlined execution and innovation in a matrix team environment.
  • Communication skills to develop constructive and effective relationships with management, team members and customers.
  • Demonstrated ability to negotiate effectively, and ability to identify and engage internal and external expertise Benefits: Medical, Dental, Vision, Life Insurance, 401K, and PTO available from your first day of hire.

About Us

Our Benefits

Seqirus is committed to attracting and retaining world-class employees who are valued for their contributions to achieving business objectives. Learn more about some of the benefits you can participate in when you join Seqirus.

About Seqirus

Seqirus is part of CSL Limited (ASX: CSL). As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. Learn more about Seqirus.

We want Seqirus to reflect the world around us

As a global organisation with employees in 35+ countries, CSL embraces diversity, equity and inclusion. Learn more about Diversity, Equity & Inclusion at Seqirus.

Do work that matters at Seqirus!


As the third largest global biotechnology company with employees in more than 35 countries, CSL Behring is focused on serving patients with serious and rare diseases, including coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease and neurological disorders. We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge and support future medical research. 

CSL Behring's dynamic environment fosters innovation and attracts the best and brightest who share a commitment to helping save lives. People here are free to live their Promising FUTURES where they can fulfill their individual career aspirations and realize their potential. 

CSL Behring is committed to diversity and inclusion, both of which underpin our Values of patient focus, innovation, collaboration, integrity and superior performance. We believe that by harnessing and honoring the unique capabilities, experiences and perspectives of our people, we are better able to serve our patients.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited, headquartered in Melbourne, Australia, employs more than 27,000 people, and provides its life-saving medicines in more than 70 countries. 
For more information visit Help us deliver on our promise to save lives and protect the health of people around the world. Promising FUTURES start at CSL Behring!

Stock Symbol: CSL

Stock Exchange: Australian Securities Exchange

Find Us
1020 First Avenue
King of Prussia
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert